Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Futurionex Initiates MiCA Application Preparation, European Compliance Strategy Enters Critical Preparation Phase

May 13, 2026

Barcelona Hosts Global Launch of “Shanghai Summer” 2026 Promotion Campaign

May 13, 2026

FDH Aero Announces Grand Opening of New Office in Bengaluru, India

May 13, 2026

Quebec tables bill allowing people to obtain domestic violence history of partners

May 13, 2026

Eternal Beauty Accelerates Offline Retail Expansion with Four New Stores Across Three Core Chinese Cities in One Month

May 13, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Arla Foods Ingredients Targets GLP-1 Companion Nutrition at Vitafoods Europe
Press Release

Arla Foods Ingredients Targets GLP-1 Companion Nutrition at Vitafoods Europe

By News RoomApril 14, 20262 Mins Read
Arla Foods Ingredients Targets GLP-1 Companion Nutrition at Vitafoods Europe
Share
Facebook Twitter LinkedIn Pinterest Email

COPENHAGEN, Denmark, April 14, 2026 (GLOBE NEWSWIRE) — Arla Foods Ingredients has developed high-protein, nutrient-dense application concepts for users of GLP-1 anti-obesity medications, which it will showcase at Vitafoods Europe (5th-7th May 2026 in Barcelona).

Originally developed to treat diabetes, GLP-1 receptor agonists have re-shaped the weight management market. In 2025, 11% of consumers globally [1] and 18% in the US [2] who were actively trying to lose weight reported using them, with uptake expected to rise as availability expands, tablet formats emerge and prices fall [3].

However, GLP-1 use is associated with side effects: lean muscle loss may reach 40% of total mass lost, versus around 25% with traditional interventions [4, 5, 6], while up to 76% of GLP-1 consumers report gastric discomfort and reduced appetite [7].

To help manufacturers address these needs, Arla Foods Ingredients has developed high-protein concepts with Nutrilac® and Lacprodan® BLG-100, delivering all essential amino acids for muscle health in nutrient-dense formats, and incorporating probiotics / cultures from Novonesis to support digestive well-being. 

The range includes great-tasting formats for reduced appetites:

  • A fermented, high-protein shot featuring Nutrilac® ProteinBoost, offering 10g of protein per 70ml serving; low fat, lactose-reduced and no added sugar.
  • A fermented, high-protein drinking yoghurt featuring Nutrilac® ProteinBoost and Nutrilac® MFGM, providing 20g protein per 200ml serving; lactose-reduced.
  • A fermented, high-protein spoonable yoghurt featuring Nutrilac® ProteinBoost, Nutrilac® YO-7700, and Capolac® milk minerals, providing 20g protein per 120g serving; high in calcium, low fat and lactose-reduced.
  • A high-protein water-based shot for ambient storage, featuring Lacprodan® BLG-100 and providing 21g of protein per 100ml serving; fat-free, sugar-free and low in lactose.

Anne Widart, Chief Commercial Officer of Arla Foods Ingredients, said: “Nutrition for GLP-1 users is a growing category, creating opportunities for dairy manufacturers. There is increasing demand for nutrient-dense, high-protein products in formats suited to smaller appetites. Our concepts are designed to help manufacturers respond to these evolving needs.”

Arla Foods Ingredients will showcase the GLP-1 companion nutrition solutions at Vitafoods Europe (Stand #3G156) alongside two additional concepts:

  • An aerated protein bar solution made with Nutrilac® PB-8420, offering high-quality milk protein and a light, soft texture enabled by stable air incorporation during processing and shelf life.
  • Ready-to-stir medical nutrition powder solutions made with Lacprodan® BLG-100 Acidic, combining a refreshing taste, no bitterness and low astringency, low viscosity at high protein levels, and good solubility in water, foods and drinks.

Photo https://www.globenewswire.com/NewsRoom/AttachmentNg/debb0da5-3fc7-43ee-93f7-b975d7eab6b0

            
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Futurionex Initiates MiCA Application Preparation, European Compliance Strategy Enters Critical Preparation Phase

Barcelona Hosts Global Launch of “Shanghai Summer” 2026 Promotion Campaign

FDH Aero Announces Grand Opening of New Office in Bengaluru, India

Eternal Beauty Accelerates Offline Retail Expansion with Four New Stores Across Three Core Chinese Cities in One Month

Shanghai Electric Unveils AI-Powered Industrial Transformation at Hannover Messe 2026

Northland Power Reports First Quarter 2026 Results

HostColor Announced RDP Server Hosting in New Data Center Locations

Crypto News Today: AlphaPepe Presale Crosses 8,600 Holders as Bitcoin Price Prediction Points To $120,000

PHR DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Phreesia (PHR) Investors of Securities Class Action Deadline on July 13, 2026

Editors Picks

Barcelona Hosts Global Launch of “Shanghai Summer” 2026 Promotion Campaign

May 13, 2026

FDH Aero Announces Grand Opening of New Office in Bengaluru, India

May 13, 2026

Quebec tables bill allowing people to obtain domestic violence history of partners

May 13, 2026

Eternal Beauty Accelerates Offline Retail Expansion with Four New Stores Across Three Core Chinese Cities in One Month

May 13, 2026

Latest News

Shanghai Electric Unveils AI-Powered Industrial Transformation at Hannover Messe 2026

May 13, 2026

Saskatoon Dragonfly delivery drivers look to unionize amid ongoing strike

May 13, 2026

Northland Power Reports First Quarter 2026 Results

May 13, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version